Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications > 2022 > Poster 2022 2
Poster 2022 2
Development and PET/CT preclinical evaluation of anti-CXCR4 antibody in triple-negative breast cancer (TNBC) murine model
Métivier C, El Ayoubi N, Le Saëc P, Garcion E, Tripier R, Haddad F, Chérel M, Huclier S, Faivre-Chauvet A, Rbah-Vidal L
15th Workshop New modalities in Cancer Imaging and Therapy, Erquy, France, october 5-8 2022